.hidden: {display:none;}; .visible: {display:block;}; Public Health & Science Policy - FaegreBD Consulting
搜索

Health & Biosciences

 Academic Medicine Rare Disease Expertise Venture Philanthropy FDA Regulatory Affairs & Product Safety Federal Government Relations - Health & Life Sciences Health Economics Media Relations - Health & Life Sciences Public Health & Science Policy Reimbursement Affairs State Government Relations - Health & Life Sciences

Public Health & Science Policy

相关新闻

TitleDate
Samantha Strong Brings Bioethics Background to FaegreBD Consulting 31 May 2016
Kelly Nickel Brings Diverse Background to Health & Biosciences Team 20 March 2016
Lauren Bloch Brings Coalition, Project Management to Health & Biosciences Team 24 September 2015
Health Markets & Reimbursement Policy Expert Bruce Quinn, M.D., Ph.D. Joins FaegreBD Consulting 20 July 2015
Mary Bono Honored for Courageous Fight Against Prescription Drug Abuse 23 April 2014

more press releases »

刊登文章

TitleDate
Internet Pharmacy Safeguards, We Salute You 11 May 2016
Regulators React to Debate Over Narrow Networks 02 May 2016
Cheers! Registries and Registrars Doing the Right Thing by Patients 07 January 2016
What Does the Future Hold for Patient-Focused Drug Development? 08 October 2015
Narrow Network Health Plans: New Approaches to Regulating Adequacy and Transparency 08 October 2015

more published articles »

媒体报道

TitleDate
Mike Adelberg Discusses Medicare Advantage Audits, Network Adequacy in Medicare Advantage News 15 July 2016
Mike Adelberg: Covered California Introduces Major Contract Changes 17 May 2016
Mike Adelberg: CMS Ties Enforcement Actions to Financial Audit, Strengthens Regulatory Hand 17 May 2016
Nick Manetto: 21st Century Cures Act Provisions to Bring 'Clarity' to Patient Experience Data Process 21 April 2016
If Losses Persist, ACA Marketplace Exits ‘Not Out of the Question,' Mike Adelberg Tells The Hill 18 April 2016

more media mentions »


DISCLAIMER

Transmission of information to us via this feature does not establish a privileged relationship. Do not send any information that you would have treated confidentially.

Decline